Vékony, H.

recurrence cancer patient bladder response tumour bacillu marker survival calmette-guerin recurrence risk treatment bcg response progression level study therapy expression polymorphism cytokine maintenance urine urology recurrence-free survival ficial bladder cancer bacillus calmette-guerin bcg treatment transurethral resection immunotherapy bladder cancer european intravesical factor outcome ficial fi rst cystoscopy recurrence-free carcinoma stage instillation macrophage 128–145 tumours resection nmibc tumor result analysis blood prognostic -67 trail interleukin il -8 levels induction transurethral –muscle bladder cancer effect il -2 table pasteur value grade group disease nucleotide saint bacillus calmette-guerin immunotherapy repair bacillus calmette-guerin response mittal rd bcg therapy calmette pmn granulocytes bcg immunotherapy responder necrosis cystoscopy ezrin urothelial